The Beauty Health Company (NASDAQ: SKIN) reported Q1 EPS of ($0.17), $0.14 worse than the analyst estimate of ($0.03). Revenue for the quarter came in at $86.3 million versus the consensus estimate of $90.69 million.

GUIDANCE:

The Beauty Health Company sees FY2023 revenue of $460-480 million, versus the consensus of $456.4 million.

• Adjusted EBITDA margin(1) 18% – 20%

For earnings history and earnings-related data on The Beauty Health Company (SKIN) click here.